V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007366 | 250012703 | 1.79 | 89 | Curative (C) | 2013-07-31 | 2013-07-31 | FLAG + Idarubicin | 02 | N | 250031900 | BUSULPHAN |
| 250007367 | 250005183 | null | 67 | Palliative (P) | 2013-03-21 | 2013-04-04 | RUXOLITINIB | N | N | 250031906 | ATG + BUSULFAN + FLUDARABINE |
| 250007368 | 250005184 | 1.59 | 60 | Palliative (P) | 2018-03-22 | 2018-03-31 | RUXOLITINIB | N | N | 250031907 | RUXOLITINIB |
| 250007369 | 250005184 | 1.8 | null | Palliative (P) | null | 2015-10-18 | RUXOLITINIB | N | null | 250031907 | IMATINIB |
| 250007371 | 250005186 | 1.6 | null | Curative (C) | 2013-09-10 | 2013-09-10 | Rituximab (Maintenance) | N | N | 250031912 | CHLORAMBUCIL |
| 250007372 | 250005187 | 0 | 82.9 | Not known (9) | 2014-08-17 | 2014-08-17 | RUXOLITINIB | N | N | 250031914 | AZACITIDINE |
| 250007373 | 250005187 | null | 54.2 | Disease modification (D) | 2016-10-03 | 2016-10-03 | Rituximab | N | N | 250031914 | TRIAL |
| 250007374 | 250005188 | 1.88 | 84 | Palliative (P) | 2014-11-14 | 2014-11-14 | RUXOLITINIB | N | N | 250031917 | THALIDOMIDE |
| 250007375 | 250009723 | 0 | null | Palliative (P) | 2018-03-12 | 2018-03-13 | RUXOLITINIB | 1 | N | 250031919 | RUXOLITINIB |
| 250007376 | 250009723 | 1.81 | 0 | Palliative (P) | 2014-11-18 | 2014-11-26 | Azacitidine | N | N | 250031919 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 250007377 | 250005189 | 0 | 76 | Disease modification (D) | 2017-06-25 | 2017-06-25 | AML 18 TRIAL | 2 | N | 250031927 | CHOP R |
| 250007378 | 250005189 | 0 | 59.95 | Disease modification (D) | 2014-01-19 | 2014-01-19 | Rituximab | 2 | N | 250031927 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 250007379 | 250011607 | 0 | 94.5 | Adjuvant (A) | 2013-01-30 | 2013-02-06 | CVP R | 2 | N | 250031930 | PEG INTERFERON |
| 250007380 | 250005190 | null | 61.2 | Palliative (P) | 2015-03-20 | 2015-03-20 | Nilotinib | 02 | N | 250031931 | RUXOLITINIB |
| 250007381 | 250005191 | 1.78 | 53 | Palliative (P) | null | 2017-05-17 | RUXOLITINIB | N | N | 250031933 | CHOP R |
| 250007382 | 250005191 | 1.67 | 58.6 | Palliative (P) | 2017-08-07 | 2017-08-07 | RUXOLITINIB | 2 | N | 250031933 | BUSULPHAN |
| 250007383 | 250005192 | 1.54 | 51.4 | Curative (C) | 2016-02-14 | 2016-02-16 | Bendamustine+Rituximab(Sub Courses) | N | N | 250031935 | BENDAMUSTINE + RITUXIMAB |
| 250007384 | 250005193 | 1.64 | 73 | Palliative (P) | 2014-09-17 | 2014-09-17 | Rituximab | 02 | N | 250031939 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250007385 | 250009726 | null | 72 | Disease modification (D) | 2014-11-10 | 2014-11-18 | RUXOLITINIB | 02 | N | 250031941 | ATG + BUSULFAN + FLUDARABINE |
| 250007388 | 250005195 | 1.7 | null | Curative (C) | 2014-10-19 | 2014-10-17 | RUXOLITINIB | 02 | N | 250031945 | MELPHALAN |
| 250007389 | 250009728 | 1.6 | 67.4 | Disease modification (D) | 2014-10-21 | 2014-11-08 | BENDAMUSTINE + RITUXIMAB | N | N | 250031947 | RUXOLITINIB |
| 250007390 | 250011608 | 0 | 72 | Palliative (P) | 2014-07-09 | 2014-07-09 | RUXOLITINIB | N | N | 250031948 | IMATINIB |
| 250007392 | 250005197 | null | 70.4 | null | 2014-06-06 | 2014-06-17 | RUXOLITINIB | Y | N | 250031952 | RUXOLITINIB |
| 250007393 | 250005197 | 1.69 | null | Curative (C) | null | 2014-08-15 | RUXOLITINIB | N | null | 250031952 | RUXOLITINIB |
| 250007394 | 250011609 | 1.52 | 73.9 | Palliative (P) | 2014-10-11 | 2014-10-11 | Rituximab | 02 | N | 250031954 | FLAG + IDARUBICIN |
| 250007395 | 250005198 | null | null | Palliative (P) | null | 2015-08-07 | RUXOLITINIB | N | N | 250031955 | BUSULPHAN |
| 250007396 | 250009730 | null | null | Palliative (P) | 2018-03-02 | 2018-03-02 | Rituximab | 2 | N | 250031957 | RUXOLITINIB |
| 250007397 | 250009730 | 1.6 | null | Palliative (P) | null | 2013-07-12 | RUXOLITINIB | N | N | 250031957 | INTERFERON |
| 250007398 | 250009730 | 1.82 | null | Adjuvant (A) | 2015-11-24 | 2015-11-24 | Alemtuzumab(INTRAVENOUS) | N | N | 250031957 | RUXOLITINIB |
| 250007399 | 250009730 | 1.65 | 72.6 | Adjuvant (A) | 2014-12-10 | 2014-12-11 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 250031957 | RUXOLITINIB |
| 250007400 | 250005199 | 1.74 | 59.5 | Palliative (P) | 2018-01-15 | 2018-01-15 | BUSULFAN | 02 | N | 250031970 | RUXOLITINIB |
| 250007401 | 250005200 | 1.78 | 0 | Curative (C) | 2018-05-04 | 2018-05-07 | RUXOLITINIB | N | N | 250031978 | RUXOLITINIB |
| 250007402 | 250005201 | 1.75 | 67 | Palliative (P) | 2016-10-27 | 2016-10-27 | Nilotinib | 2 | N | 250031979 | RITUXIMAB |
| 250007403 | 250009731 | null | null | Curative (C) | 2015-02-14 | 2015-02-14 | RUXOLITINIB | 02 | null | 250031982 | RITUXIMAB |
| 250007404 | 250005202 | 1.77 | 80 | Adjuvant (A) | 2016-09-10 | 2017-08-24 | RUXOLITINIB | 2 | N | 250031984 | CHOP R |
| 250007405 | 250005203 | null | null | Palliative (P) | 2017-01-04 | 2017-01-04 | INTERFERON | 2 | N | 250031985 | BUSULPHAN |
| 250007406 | 250009732 | null | null | null | 2016-07-26 | 2016-07-27 | CYTARABINE + ETOPOSIDE + IDARUBICIN | 01 | null | 250031986 | RITUXIMAB |
| 250007407 | 250005204 | 1.73 | 72 | Not known (9) | 2017-10-29 | 2017-10-29 | RUXOLITINIB | 02 | N | 250031987 | RUXOLITINIB |
| 250007408 | 250005204 | null | 89 | Palliative (P) | 2014-02-21 | 2014-03-20 | IMATINIB | null | N | 250031987 | AZACITIDINE |
| 250007409 | 250005204 | 1.7 | null | Palliative (P) | null | 2013-03-26 | Cytarabine High Dose | null | N | 250031987 | RUXOLITINIB |
| 250007410 | 250005205 | 1.82 | 84.6 | Palliative (P) | 2014-09-02 | 2014-09-16 | Vinorelbine (oral) | N | N | 250031990 | CARBOPLATIN + ETOPOSIDE |
| 250007411 | 250005205 | 1.81 | 76.5 | Palliative (P) | 2013-12-06 | 2013-12-06 | CVP R | Y | N | 250031990 | RUXOLITINIB |
| 250007413 | 250005207 | 1.55 | 50.2 | Disease modification (D) | 2016-01-22 | 2016-01-22 | RUXOLITINIB | N | N | 250031999 | CYTARABINE |
| 250007414 | 250005208 | null | 67 | Palliative (P) | 2015-04-07 | 2015-05-06 | PEG INTERFERON | null | N | 250032000 | RITUXIMAB |
| 250007415 | 250005208 | 0 | 62.3 | Disease modification (D) | 2013-12-09 | 2014-01-01 | HYDROCORTISONE IT + METHOTREXATE IT | N | N | 250032000 | CHOP R |
| 250007417 | 250005210 | null | 61.9 | null | 2017-02-03 | 2017-02-03 | Trial Unspecified | N | null | 250032009 | RITUXIMAB |
| 250007418 | 250005211 | 1.8 | null | Disease modification (D) | 2014-06-01 | 2014-06-09 | PEG INTERFERON | null | N | 250032010 | RITUXIMAB |
| 250007419 | 250009736 | 1.55 | 72.9 | Palliative (P) | 2014-01-25 | 2014-02-22 | Trial Unspecified | N | N | 250032011 | RITUXIMAB |
| 250007420 | 250009736 | 1.8 | 0 | Palliative (P) | 2013-09-28 | 2013-09-28 | Pazopanib | 2 | N | 250032011 | CVP R |
| 250007421 | 250009736 | 1.85 | 80 | Palliative (P) | 2018-04-17 | 2018-04-17 | RUXOLITINIB | null | N | 250032011 | RUXOLITINIB |